Stay updated on Immunotherapy Plus Radiation for Merkel Cell Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Immunotherapy Plus Radiation for Merkel Cell Carcinoma Clinical Trial page.
Latest updates to the Immunotherapy Plus Radiation for Merkel Cell Carcinoma Clinical Trial page
- Check4 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.0%
- Check12 days agoChange DetectedThe website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this functionality.SummaryDifference0.1%
- Check19 days agoChange DetectedA new Pembrolizumab biosimilar (RPH-075) has been added with an estimated last update posted on December 3, 2024, while previous updates from November 9 and 13, 2024, have been removed.SummaryDifference0.5%
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.0%
- Check41 days agoChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information for individuals who can answer questions about joining the study and includes a reference to the 'Contacts and Locations' section in the study record.SummaryDifference1%
- Check55 days agoChange DetectedThe website has added a 'Show less' option while removing extensive details related to participant groups, interventions, and various data fields available for download.SummaryDifference2%
Stay in the know with updates to Immunotherapy Plus Radiation for Merkel Cell Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy Plus Radiation for Merkel Cell Carcinoma Clinical Trial page.